Arrowgrass Capital Partners (US)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-37,873	Closed	-$5.72M	–	220
2018 Q1	$5.72M	Sell	37,873 -81,929	-68%	-$12M	0.22%	69
2017 Q4	$16.1M	Sell	119,802 -27,922	-19%	-$3.87M	0.38%	162
2017 Q3	$21.6M	Buy	147,724 +36,816	+33%	+$5.57M	0.36%	155
2017 Q2	$17.2M	Buy	110,908 +54,286	+96%	+$8.3M	0.28%	205
2017 Q1	$8.22M	Buy	+56,622	New	+$7.37M	0.2%	274
2016 Q4	–	Sell	-65,648	Closed	-$7.97M	–	558
2016 Q3	$7.97M	Sell	65,648 -44,455	-40%	-$5.99M	0.2%	157
2016 Q2	$15.6M	Buy	110,103 +32,683	+42%	+$4.82M	0.35%	91
2016 Q1	$10.1M	Sell	77,420 -33,546	-30%	-$4.18M	0.21%	118
2015 Q4	$15.6M	Buy	110,966 +2,944	+3%	+$408K	0.31%	75
2015 Q3	$14.3M	Sell	108,022 -13,169	-11%	-$2.27M	0.5%	67
2015 Q2	$21.3M	Buy	121,191 +11,309	+10%	+$2.03M	0.6%	62
2015 Q1	$19M	Buy	109,882 +48,621	+79%	+$8.34M	0.57%	49
2014 Q4	$10M	Buy	+61,261	New	+$10.2M	0.28%	83